Dáil Éireann Debate, Tuesday - 28 February 2023
620. Deputy Jim O'Callaghan asked the Minister for Health whether his Department is exploring the option of introducing legislation to facilitate increased biosimilar use and or introducing pharmacy-level substitution for biosimilars. [9999/23]
View answerMy Department is working with colleagues from the Health Products Regulatory Authority (HPRA) and the Health Service Executive (HSE) to consider the European Medicines Agency's ruling and other initiatives to optimise the use of biosimilar and generic medicines.
